Target intelligence / Profile preview

Inositol 1,4,5-trisphosphate receptor (IP3R) (IP3R)

Target
IP3R
Molecular classification
Ion channel, Receptor, Intracellular calcium release channel
01

Overview

The Inositol 1,4,5-trisphosphate receptor (IP3R) is a family of large, tetrameric ligand-gated calcium channels primarily localized to the endoplasmic reticulum (ER) membrane (UniProt, 2023). These receptors are essential for intracellular calcium signaling, as they release Ca2+ from internal stores into the cytoplasm in response to the second messenger IP3, which is produced by phospholipase C (PLC) activation (Mikoshiba, 2007). The family comprises three main isoforms—IP3R1, IP3R2, and IP3R3—which exhibit different affinities for IP3 and are regulated by various factors including cytosolic calcium, ATP, and phosphorylation (Prole & Taylor, 2019). IP3Rs are involved in a vast array of physiological processes, ranging from muscle contraction and neurotransmission to cell division and apoptosis (PubMed, 2022). Dysregulation of these receptors is linked to numerous diseases, such as spinocerebellar ataxia type 15/16 (ITPR1 mutations) and various malignancies where IP3R-mediated calcium transfer to mitochondria influences cell survival (StatPearls, 2023). Although several small molecules like Xestospongin C and 2-APB are used in research to modulate IP3R activity, the development of clinical therapeutics remains challenging due to the receptors' ubiquitous expression and the risk of disrupting fundamental cellular calcium homeostasis (Alzayady et al., 2016).

Other names
IP3 receptorInsP3RITPRInositol trisphosphate receptorInositol 1,4,5-triphosphate receptor
02

Mechanism of action

The IP3 receptor family functions as ligand-gated calcium channels that release calcium ions from the endoplasmic reticulum into the cytosol upon binding of the second messenger inositol 1,4,5-trisphosphate (IP3) (Mikoshiba, 2007; UniProt, 2023).

03

Biological functions

Signal transductionCalcium signalingApoptosisCell proliferationAutophagyFertilizationSynaptic plasticity
04

Disease associations

Neurodegenerative diseaseCancerCardiovascular diseaseDiabetesSpinocerebellar ataxiaGilles de la Tourette syndrome
05

Safety considerations

Ubiquitous expression leading to potential systemic toxicityRisk of disrupting essential calcium-dependent signaling pathwaysPotential for inducing apoptosis or cellular stressCardiac arrhythmia risk due to altered calcium handling
06

Interacting drugs

Caffeine

4 more in the full profile.

07

Biomarkers

ITPR1 protein expressionITPR2 protein expressionITPR3 protein expressionIntracellular calcium transientsCytosolic calcium concentration

Beyond the preview

Go deeper on Inositol 1,4,5-trisphosphate receptor (IP3R) (IP3R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inositol 1,4,5-trisphosphate receptor (IP3R) (IP3R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call